Research ArticleArticle
Low Copy Number of the Fc-γ Receptor 3B Gene FCGR3B Is a Risk Factor for Primary Sjögren's Syndrome
Johannes C. Nossent, Maureen Rischmueller and Sue Lester
The Journal of Rheumatology September 2012, jrheum.120294; DOI: https://doi.org/10.3899/jrheum.120294
Johannes C. Nossent
From the Department of Rheumatology, Basil Hetzel Institute, The Queen Elizabeth Hospital, Adelaide, Australia; Department of Rheumatology, Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway; and the Discipline of Medicine, University of Adelaide, Adelaide, Australia. Supported by grants from the Norwegian Rheumatism Association, the North Norwegian Health Authority, and the Hospital Research Foundation. J.C. Nossent, MD, PhD, Department of Rheumatology, Basil Hetzel Institute, The Queen Elizabeth Hospital, and Department of Rheumatology, Institute of Clinical Medicine, University of Tromsø; M. Rischmueller, MD, Department of Rheumatology, Basil Hetzel Institute, The Queen Elizabeth Hospital, and Discipline of Medicine, University of Adelaide; S. Lester, BSc (Hons), Department of Rheumatology, Basil Hetzel Institute, The Queen Elizabeth Hospital. Address correspondence to S. Lester, Department of Rheumatology, The Queen Elizabeth Hospital, 28 Woodville Road, Woodville South, 5022 South Australia, Australia. E-mail: susan.lester@health.sa.gov.au Accepted for publication July 6, 2012.
Maureen Rischmueller
From the Department of Rheumatology, Basil Hetzel Institute, The Queen Elizabeth Hospital, Adelaide, Australia; Department of Rheumatology, Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway; and the Discipline of Medicine, University of Adelaide, Adelaide, Australia. Supported by grants from the Norwegian Rheumatism Association, the North Norwegian Health Authority, and the Hospital Research Foundation. J.C. Nossent, MD, PhD, Department of Rheumatology, Basil Hetzel Institute, The Queen Elizabeth Hospital, and Department of Rheumatology, Institute of Clinical Medicine, University of Tromsø; M. Rischmueller, MD, Department of Rheumatology, Basil Hetzel Institute, The Queen Elizabeth Hospital, and Discipline of Medicine, University of Adelaide; S. Lester, BSc (Hons), Department of Rheumatology, Basil Hetzel Institute, The Queen Elizabeth Hospital. Address correspondence to S. Lester, Department of Rheumatology, The Queen Elizabeth Hospital, 28 Woodville Road, Woodville South, 5022 South Australia, Australia. E-mail: susan.lester@health.sa.gov.au Accepted for publication July 6, 2012.
Sue Lester
From the Department of Rheumatology, Basil Hetzel Institute, The Queen Elizabeth Hospital, Adelaide, Australia; Department of Rheumatology, Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway; and the Discipline of Medicine, University of Adelaide, Adelaide, Australia. Supported by grants from the Norwegian Rheumatism Association, the North Norwegian Health Authority, and the Hospital Research Foundation. J.C. Nossent, MD, PhD, Department of Rheumatology, Basil Hetzel Institute, The Queen Elizabeth Hospital, and Department of Rheumatology, Institute of Clinical Medicine, University of Tromsø; M. Rischmueller, MD, Department of Rheumatology, Basil Hetzel Institute, The Queen Elizabeth Hospital, and Discipline of Medicine, University of Adelaide; S. Lester, BSc (Hons), Department of Rheumatology, Basil Hetzel Institute, The Queen Elizabeth Hospital. Address correspondence to S. Lester, Department of Rheumatology, The Queen Elizabeth Hospital, 28 Woodville Road, Woodville South, 5022 South Australia, Australia. E-mail: susan.lester@health.sa.gov.au Accepted for publication July 6, 2012.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Low Copy Number of the Fc-γ Receptor 3B Gene FCGR3B Is a Risk Factor for Primary Sjögren's Syndrome
Johannes C. Nossent, Maureen Rischmueller, Sue Lester
The Journal of Rheumatology Sep 2012, jrheum.120294; DOI: 10.3899/jrheum.120294